Prism Medico and Pharmacy Limited (BOM:512217)
35.99
-0.19 (-0.53%)
At close: Nov 11, 2026
Prism Medico and Pharmacy Revenue
Prism Medico and Pharmacy had revenue of 8.55M INR in the twelve months ending June 30, 2026, down -60.39% year-over-year. In the fiscal year ending March 31, 2026, Prism Medico and Pharmacy had annual revenue of 24.43M with 286.68% growth. That makes Prism Medico and Pharmacy the 46,166th largest company in the world by revenue and 5,080th in India.
Revenue (ttm)
8.55M
Revenue Growth
-60.39%
P/S Ratio
25.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
218.22M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 24.43M | 18.12M | 286.68% |
| Mar 31, 2025 | 6.32M | -22.93M | -78.40% |
| Apr 1, 2024 | 29.25M | 16.55M | 130.21% |
| Apr 1, 2023 | 12.71M | -71.73M | -84.95% |
| Apr 1, 2022 | 84.44M | -83.19M | -49.63% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Om Metallogic | 751.30M |
| Q&T Foods | 547.76M |
| Gorani Industries | 306.69M |
| Jay Kailash Namkeen | 174.62M |
| Dhyaani Tradeventtures | 118.94M |
| Skybiotech Healthcare | 55.35M |
| Navigant Corporate Advisors | 49.06M |
| Lesha Industries | 46.21M |